Reuters logo
BRIEF-Otsuka Holdings, Lundbeck initiate two phase 3 trials of Brexpiprazole
October 11, 2017 / 10:28 PM / 12 days ago

BRIEF-Otsuka Holdings, Lundbeck initiate two phase 3 trials of Brexpiprazole

Oct 11 (Reuters) - Otsuka Holdings Co Ltd

* Otsuka and lundbeck announce initiation of two phase 3 trials of brexpiprazole in patients with Bipolar I disorder Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below